SOFTMAX CoTSE:3671 +0.32%70 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:3671 with a GF Score™ of 70/100 and a GF Value™ of 円281.78 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 664 Healthcare Providers & Services companies, SOFTMAX Co ranks worse than 52.26% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. SOFTMAX Co's EBITDA for the
three
months ended in Dec. 2025 was 円0 Mil. SOFTMAX Co's Revenue for the
three
months ended in Dec. 2025 was 円0 Mil. Therefore, SOFTMAX Co's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.
SOFTMAX Co (TSE:3671) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
SOFTMAX Co EBITDA Margin % Related Terms
SOFTMAX Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for SOFTMAX Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3671 vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, SOFTMAX Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOFTMAX Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SOFTMAX Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where SOFTMAX Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOFTMAX Co (TSE:3671) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on SOFTMAX Co and its competitors. Over the past decade, SOFTMAX Co's EBITDA Margin % has ranged from 1.58 to 14.53. According to the industry distribution chart, SOFTMAX Co ranks #347 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 52.3%.
Is SOFTMAX Co's EBITDA Margin % too high?
SOFTMAX Co's current EBITDA Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 1.58 to a high of 14.53. Based on the distribution chart, SOFTMAX Co ranks #347 out of 664 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, SOFTMAX Co has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOFTMAX Co's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SOFTMAX Co ranks #347 out of 664 companies for EBITDA Margin %. This places SOFTMAX Co in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Historically, SOFTMAX Co's own EBITDA Margin % has ranged from 1.58 to 14.53 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on SOFTMAX Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOFTMAX Co's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOFTMAX Co stock overvalued right now?
Based on GuruFocus' analysis, SOFTMAX Co (TSE:3671) is currently considered Modestly Overvalued. The stock's GF Value™ is 円281.78, compared to a current price of 円315.00 — trading 11.8% above its estimated fair value. The current EBITDA Margin % is 0.00%. SOFTMAX Co's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For SOFTMAX Co (TSE:3671), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SOFTMAX Co (TSE:3671) Overvalued in 2026?
Based on GuruFocus' analysis, SOFTMAX Co stock appears to be overvalued.
The current stock price of 円315.00 is trading 11.8% above its estimated GF Value™ of 円281.78.
GuruFocus considers SOFTMAX Co to be Modestly Overvalued.
Key valuation signals for TSE:3671:
EBITDA Margin %: 0.00%
GF Value™: 円281.78 vs. price of 円315.00 (11.8% above fair value)
No single metric tells the full story. See the TSE:3671 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SOFTMAX Co Ltd provides optimal solutions for customers based on their developed PlusUs series such as Web type electronic charts and medical accounting. It offers Web-type electronic medical record and ordering systems, health checkup systems, radiology department information systems, rehabilitation department systems, surgical department systems, hospital goods management systems, and nursing care management systems. Geographically it operates through the region of Japan.
70GF Score
Get the complete analysis for TSE:3671
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3671 has been successfully added to your 
